ESC 365 - Detailed description of myocardial infarctions and the various subtypes in the LEADER trial

ESC Premium Access

Detailed description of myocardial infarctions and the various subtypes in the LEADER trial

Session: Diabetes mellitus: from "omics to complications"

Topic: Diabetes, dysglycaemia and metabolic syndrome

Speaker: Professor M. Nauck (Bochum, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Michael Nauck

Ruhr University Bochum, Bochum (Germany)

0 follower

6 more presentations in this session

Use of insulin providers versus insulin sensitizers and risk of out-of-hospital cardiac arrest - a nationwide case-time-control study

Speaker: Mr G. Hognason Mohr (Copenhagen, DK)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial

Speaker: Doctor T. Aung (Oxford, GB)

Diabetes risk assessment of cardiovascular free individuals, through the calculation and evaluation of a lifestyle index; results of the 10-year follow up of the ATTICA study.

Speaker: Professor D. Panagiotakos (Athens, GR)

Genome-wide DNA methylation analysis for type 2 diabetes mellitus and cardiovascular disease: from a 23-Year follow-up in the Da Qing Diabetes Prevention Study

Association of subclinical atherosclerosis with telomere length and glycemic variability

Speaker: Doctor E. Dudinskaya (Moscow, RU)

Access the full session

Diabetes mellitus: from "omics to complications"

Speakers: Professor M. Nauck, Mr G. Hognason Mohr, Doctor T. Aung, Professor D. Panagiotakos, Doctor E. Dudinskaya

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources